We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+29%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.1B
AUM Growth
+$1.94B
Cap. Flow
-$956M
Cap. Flow %
-6.31%
Top 10 Hldgs %
19.25%
Holding
1,647
New
467
Increased
323
Reduced
312
Closed
527

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$208M
2
JNJ icon
Johnson & Johnson
JNJ
+$190M
3
PFE icon
Pfizer
PFE
+$166M
4
NVDA icon
NVIDIA
NVDA
+$154M
5
ADBE icon
Adobe
ADBE
+$134M

Sector Composition

Rank Sector Weight
1 Healthcare 27.79%
2 Technology 18.34%
3 Consumer Discretionary 12.92%
4 Financials 8.19%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WW
651
DELISTED
WW International
WW
$1.5M 0.01%
+59,198
New +$1.38M
NDLS icon
652
Noodles & Co
NDLS
$96M
$1.5M 0.01%
30,906
-9,941
-24% -$422K
MGPI icon
653
MGP Ingredients
MGPI
$381M
$1.49M 0.01%
+40,545
New +$1.45M
BFAM icon
654
Bright Horizons
BFAM
$3.81B
$1.48M 0.01%
12,659
-17,909
-59% -$2.04M
WPP icon
655
WPP
WPP
$5.76B
$1.48M 0.01%
+37,862
New +$1.41M
NXTC icon
656
NextCure
NXTC
$31.3M
$1.48M 0.01%
5,754
-14,159
-71% -$5.39M
API
657
Agora
API
$386M
$1.48M 0.01%
+33,500
New +$1.58M
MNDT
658
DELISTED
Mandiant, Inc. Common Stock
MNDT
$1.46M 0.01%
120,067
-27,696
-19% -$321K
VRM icon
659
Vroom Inc
VRM
$51.2M
$1.46M 0.01%
+350
New +$1.36M
IT icon
660
Gartner
IT
$12.2B
$1.46M 0.01%
+12,020
New +$1.39M
ADCT icon
661
ADC Therapeutics
ADCT
$144M
$1.45M 0.01%
+30,990
New +$1.18M
CYBR
662
DELISTED
CyberArk
CYBR
$1.44M 0.01%
+14,537
New +$1.41M
BATRK icon
663
Atlanta Braves Holdings Series B
BATRK
$3.21B
$1.43M 0.01%
+72,482
New +$1.44M
ODFL icon
664
Old Dominion Freight Line
ODFL
$44.1B
$1.43M 0.01%
+16,862
New +$1.28M
ATRA icon
665
Atara Biotherapeutics
ATRA
$77.6M
$1.43M 0.01%
+3,926
New +$992K
DLTH icon
666
Duluth Holdings
DLTH
$151M
$1.43M 0.01%
193,671
+1,154
+0.6% +$5.89K
BWIN
667
Baldwin Insurance Group
BWIN
$2.79B
$1.43M 0.01%
+82,695
New +$998K
HTGC icon
668
Hercules Capital
HTGC
$3.21B
$1.43M 0.01%
136,090
+126,696
+1,349% +$1.29M
CERS icon
669
Cerus
CERS
$508M
$1.42M 0.01%
+215,592
New +$1.24M
IRT icon
670
Independence Realty Trust
IRT
$3.94B
$1.42M 0.01%
123,164
-110,803
-47% -$1.11M
GMS
671
DELISTED
GMS Inc
GMS
$1.41M 0.01%
+57,494
New +$1.1M
AVNS
672
DELISTED
Avanos Medical
AVNS
$1.4M 0.01%
47,595
+10,785
+29% +$312K
VALE icon
673
Vale
VALE
$63.4B
$1.4M 0.01%
135,628
-334,750
-71% -$3.06M
MCD icon
674
McDonald's
MCD
$194B
$1.4M 0.01%
+7,561
New +$1.39M
FSKR
675
DELISTED
FS KKR Capital Corp. II
FSKR
$1.37M 0.01%
+106,563
New +$1.41M

Similar funds

Marshall Wace North America's Q2 2020 Portfolio in Review

As of Q2 2020, Marshall Wace North America held 1,647 positions worth $15.1B, up 15% from $13.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America withdrew a net $956M in Q2 2020, closing 527 positions and reducing 312 holdings. Its most notable exit was Becton Dickinson, an estimated $86.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Motorola Solutions worth $88.4M.

  • Marshall Wace North America's largest Q2 2020 buy was Motorola Solutions: 630,587 shares worth $88.4M.
  • Marshall Wace North America added most to JPMorgan Chase in Q2 2020, an estimated $148M increase.
  • Marshall Wace North America's biggest Q2 2020 reduction was Merck, cutting an estimated $208M.
  • Marshall Wace North America fully exited Becton Dickinson in Q2 2020, selling an estimated $86.4M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $15.1B portfolio in Q2 2020.
  • Marshall Wace North America opened 467 new positions and closed 527 in Q2 2020.
  • Marshall Wace North America's portfolio value rose 15% quarter-over-quarter to $15.1B.

Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.